Search results
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
The Yuma Sun· 16 hours agoThe ASCO Annual Meeting is being held online and in person in Chicago, Illinois from May 31 to June 4, 2024. The EHA2024 Congress is being held online and in person in Madrid, Spain from June 13 to June 16, 2024.
Syrian first lady Asma Assad diagnosed with leukemia, president's office says
Associated Press via Yahoo News· 3 days agoSyrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad...
Recommendations from the AML molecular MRD expert advisory board - Leukemia
Nature· 1 day agoThe standard-of-care treatment for patients with acute myeloid leukemia (AML) is being challenged by new classes of targeted therapies ...
St. Jude patient's lifesaving story: 'I was losing my ability to function at that point'
ABC 13 Lynchburg· 2 days agoDoctors diagnosed Anna with acute myeloid leukemia, an aggressive form of the disease, when she was...
Syrian first lady diagnosed with leukemia
China Daily· 3 days agoSyrian First Lady Asma al-Assad has been diagnosed with acute myeloid leukemia, a type of blood cancer, the Syrian presidency said in ...
In the news | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 2 days agoAsma Assad, wife of Syrian President Bashar Assad, was diagnosed with acute myeloid leukemia -- an aggressive cancer of the bone marrow ...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
WJTV Jackson· 12 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 20 hours agoThe drug is at the center of Novartis’ pending $2.9 billion acquisition of MorphoSys, but there are questions about its safety after a Stat report...
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells - Leukemia
Nature· 2 days agoMyelodysplastic syndromes (MDS) are malignant bone marrow disorders characterized by ineffective hematopoiesis leading to refractory cytopenias and an increased risk of progression to
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 8 hours agoStockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...
